Read + Share
Amedeo Smart
Independent Medical Education
Yen HH, Su PY, Zeng YH, Liu IL, et al. Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting. PLoS One 2020;15:e0237582.PMID: 32790715
Email
LinkedIn
Facebook
Twitter
Privacy Policy